Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)

Antonio Vitale; Giacomo Emmi; Giuseppe Lopalco; Claudia Fabiani; Stefano Gentileschi; Elena Silvestri; Gerardo Di Scala; Florenzo Iannone; Bruno Frediani; Mauro Galeazzi; Giovanni Lapadula; Donato Rigante; Luca Cantarini

doi:10.1007/s10067-018-4302-0

Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)

Antonio Vitale, Giacomo Emmi, Giuseppe Lopalco, Claudia Fabiani, Stefano Gentileschi, Elena Silvestri, Gerardo Di Scala, Florenzo Iannone, Bruno Frediani, Mauro Galeazzi, Giovanni Lapadula, Donato Rigante, Luca Cantarini

IRCCS Fondazione Policlinico Universitario A. Gemelli

Research output: Contribution to journal › Article › peer-review

Abstract

In the original version of this article the author name Gerardo Di Scala was originally presented incorrectly as ‘Di Scala Gerardo’; this has been corrected in this article.

Original language	English
Journal	Clinical Rheumatology
DOIs	https://doi.org/10.1007/s10067-018-4302-0
Publication status	Accepted/In press - Jan 1 2018

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1007/s10067-018-4302-0

Fingerprint Dive into the research topics of 'Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)'. Together they form a unique fingerprint.

Cite this

Vitale, A., Emmi, G., Lopalco, G., Fabiani, C., Gentileschi, S., Silvestri, E., Di Scala, G., Iannone, F., Frediani, B., Galeazzi, M., Lapadula, G., Rigante, D., & Cantarini, L. (Accepted/In press). Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4). Clinical Rheumatology. https://doi.org/10.1007/s10067-018-4302-0

Correction to : Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4). / Vitale, Antonio; Emmi, Giacomo; Lopalco, Giuseppe; Fabiani, Claudia; Gentileschi, Stefano; Silvestri, Elena; Di Scala, Gerardo; Iannone, Florenzo; Frediani, Bruno; Galeazzi, Mauro; Lapadula, Giovanni; Rigante, Donato; Cantarini, Luca.

In: Clinical Rheumatology, 01.01.2018.

Research output: Contribution to journal › Article › peer-review

Vitale, A, Emmi, G, Lopalco, G, Fabiani, C, Gentileschi, S, Silvestri, E, Di Scala, G, Iannone, F, Frediani, B, Galeazzi, M, Lapadula, G, Rigante, D & Cantarini, L 2018, 'Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)', Clinical Rheumatology. https://doi.org/10.1007/s10067-018-4302-0

Vitale, Antonio ; Emmi, Giacomo ; Lopalco, Giuseppe ; Fabiani, Claudia ; Gentileschi, Stefano ; Silvestri, Elena ; Di Scala, Gerardo ; Iannone, Florenzo ; Frediani, Bruno ; Galeazzi, Mauro ; Lapadula, Giovanni ; Rigante, Donato ; Cantarini, Luca. / Correction to : Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4). In: Clinical Rheumatology. 2018.

@article{2ee66579a6c24b6f819c2d9bb0709cfe,

title = "Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Beh{\c c}et{\textquoteright}s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)",

abstract = "In the original version of this article the author name Gerardo Di Scala was originally presented incorrectly as {\textquoteleft}Di Scala Gerardo{\textquoteright}; this has been corrected in this article.",

author = "Antonio Vitale and Giacomo Emmi and Giuseppe Lopalco and Claudia Fabiani and Stefano Gentileschi and Elena Silvestri and {Di Scala}, Gerardo and Florenzo Iannone and Bruno Frediani and Mauro Galeazzi and Giovanni Lapadula and Donato Rigante and Luca Cantarini",

year = "2018",

month = jan,

day = "1",

doi = "10.1007/s10067-018-4302-0",

language = "English",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer London",

}

TY - JOUR

T1 - Correction to

T2 - Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)

AU - Vitale, Antonio

AU - Emmi, Giacomo

AU - Lopalco, Giuseppe

AU - Fabiani, Claudia

AU - Gentileschi, Stefano

AU - Silvestri, Elena

AU - Di Scala, Gerardo

AU - Iannone, Florenzo

AU - Frediani, Bruno

AU - Galeazzi, Mauro

AU - Lapadula, Giovanni

AU - Rigante, Donato

AU - Cantarini, Luca

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In the original version of this article the author name Gerardo Di Scala was originally presented incorrectly as ‘Di Scala Gerardo’; this has been corrected in this article.

AB - In the original version of this article the author name Gerardo Di Scala was originally presented incorrectly as ‘Di Scala Gerardo’; this has been corrected in this article.

UR - http://www.scopus.com/inward/record.url?scp=85053696953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053696953&partnerID=8YFLogxK

U2 - 10.1007/s10067-018-4302-0

DO - 10.1007/s10067-018-4302-0

M3 - Article

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

ER -